A novel molecular pathway that causes an aggressive form of medulloblastoma has been reported by an international research team in emNature Medicine/em. They suggest repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children. The multi-institutional group, led by scientists at Cancer and Blood Diseases Institute (CBDI) at Cincinnati Children's Hospital Medical Center, publish their results ...Monday 25 August 2014
Medulloblastoma Targeting By Repurposing Anti-Depressant Medication
A novel molecular pathway that causes an aggressive form of medulloblastoma has been reported by an international research team in emNature Medicine/em. They suggest repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children. The multi-institutional group, led by scientists at Cancer and Blood Diseases Institute (CBDI) at Cincinnati Children's Hospital Medical Center, publish their results ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment